791 related articles for article (PubMed ID: 10578046)
21. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
Brockhausen I; Dowler T; Paulsen H
Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
[TBL] [Abstract][Full Text] [Related]
22. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
23. Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen.
Schuman J; Campbell AP; Koganty RR; Longenecker BM
J Pept Res; 2003 Mar; 61(3):91-108. PubMed ID: 12558945
[TBL] [Abstract][Full Text] [Related]
24. Distinct orders of GalNAc incorporation into a peptide with consecutive threonines.
Kato K; Takeuchi H; Miyahara N; Kanoh A; Hassan H; Clausen H; Irimura T
Biochem Biophys Res Commun; 2001 Sep; 287(1):110-5. PubMed ID: 11549261
[TBL] [Abstract][Full Text] [Related]
25. Mucin-type O-glycosylation in Mesocestoides vogae (syn. corti).
Medeiros A; Chiribao ML; Ubillos L; Festari MF; Saldaña J; Robello C; Domínguez L; Calvete JJ; Osinaga E
Int J Parasitol; 2008 Mar; 38(3-4):265-76. PubMed ID: 17892882
[TBL] [Abstract][Full Text] [Related]
26. High density O-glycosylation of the MUC2 tandem repeat unit by N-acetylgalactosaminyltransferase-3 in colonic adenocarcinoma extracts.
Inoue M; Takahashi S; Yamashina I; Kaibori M; Okumura T; Kamiyama Y; Vichier-Guerre S; Cantacuzène D; Nakada H
Cancer Res; 2001 Feb; 61(3):950-6. PubMed ID: 11221889
[TBL] [Abstract][Full Text] [Related]
27. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
Huang J; Byrd JC; Yoon WH; Kim YS
Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
[TBL] [Abstract][Full Text] [Related]
28. Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides.
Hanisch FG; Reis CA; Clausen H; Paulsen H
Glycobiology; 2001 Sep; 11(9):731-40. PubMed ID: 11555617
[TBL] [Abstract][Full Text] [Related]
29. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies.
Spencer DI; Price MR; Tendler SJ; De Matteis CI; Stadie T; Hanisch FG
Cancer Lett; 1996 Feb; 100(1-2):11-5. PubMed ID: 8620429
[TBL] [Abstract][Full Text] [Related]
30. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
[TBL] [Abstract][Full Text] [Related]
31. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
[TBL] [Abstract][Full Text] [Related]
32. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
[TBL] [Abstract][Full Text] [Related]
34. In vivo glycosylation of mucin tandem repeats.
Silverman HS; Parry S; Sutton-Smith M; Burdick MD; McDermott K; Reid CJ; Batra SK; Morris HR; Hollingsworth MA; Dell A; Harris A
Glycobiology; 2001 Jun; 11(6):459-71. PubMed ID: 11445551
[TBL] [Abstract][Full Text] [Related]
35. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
Ho SB; Ewing SL; Montgomery CK; Kim YS
Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
[TBL] [Abstract][Full Text] [Related]
36. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
37. Non-glycosylated tandem repeats of MUC1 facilitate attachment of breast tumor cells to normal human lung tissue and immobilized extracellular matrix proteins (ECM) in vitro: potential role in metastasis.
Ciborowski P; Finn OJ
Clin Exp Metastasis; 2002; 19(4):339-45. PubMed ID: 12090474
[TBL] [Abstract][Full Text] [Related]
38. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.
Fernandez-Rodriguez J; Dwir O; Alon R; Hansson GC
Glycoconj J; 2001; 18(11-12):925-30. PubMed ID: 12820726
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).
Kubota T; Shiba T; Sugioka S; Furukawa S; Sawaki H; Kato R; Wakatsuki S; Narimatsu H
J Mol Biol; 2006 Jun; 359(3):708-27. PubMed ID: 16650853
[TBL] [Abstract][Full Text] [Related]
40. A MUC1 tandem repeat reporter protein produced in CHO-K1 cells has sialylated core 1 O-glycans and becomes more densely glycosylated if coexpressed with polypeptide-GalNAc-T4 transferase.
Olson FJ; Bäckström M; Karlsson H; Burchell J; Hansson GC
Glycobiology; 2005 Feb; 15(2):177-91. PubMed ID: 15456735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
